Mitsubishi Tanabe Pharma Corp.

Pharmaceuticals
Japan
2016 Revenue (US$ Millions)$3,625
Revenue Growth (%)-1.79%
Net Income (US$ Millions)$609
Earnings Per Share (US$)NA
EPS Growth Rate (%)NA
Profit Margin16.81%
Total Equity (US$ Millions)$7,357
Return on Equity (%)8.84%
Long Term Debt (US$ Millions)$5
Debt To Equity Ratio (%)0.00%
Total Assets (US$ Millions)$8,418
Current Assets (US$ Millions)$5,846
Current Liabilities (US$ Millions)$756
Cost of Goods Sold (US$ Millions)$1,406
Inventory Turnover2.12